Marchant Erik D, Singh Ekta, Kureel Sanjay, Blair Brandon, Kalenta Hanna, Von Ruff Zachary D, Weldon Korri S, Lai Zhao, Sheetz Michael P, Rasmussen Blake B
Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States.
Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E899-E910. doi: 10.1152/ajpendo.00470.2024. Epub 2025 May 5.
The risk for developing insulin resistance and type II diabetes increases with age. Although lifestyle factors contribute to age-related insulin resistance, aging itself independently reduces insulin sensitivity, partially via an increase in inflammation and cellular senescence. Low-frequency ultrasound (LFU) has been shown to rejuvenate senescent cells and to reduce the proinflammatory senescence-associated secretory phenotype. Because diabetes is more common in aged individuals, there is an increased need to develop effective therapeutics for aged individuals with this condition. This study investigated the effects of LFU treatment on muscle function, blood glucose control, and skeletal muscle gene expression in aged, insulin-resistant, and diabetic mice. Insulin resistance was induced via a high-fat, high-sucrose (HFHS) diet, and diabetes was induced via an HFHS diet plus a low dose of streptozotocin. Insulin-resistant and diabetic mice exhibited impaired glucose metabolism and physical function, as well as an altered transcriptomic profile in skeletal muscle, indicating an increase in inflammation and an immune response. LFU treatment reversed much of the transcriptomic changes that occurred with insulin resistance and diabetes but had no effect on blood glucose control or physical function. LFU demonstrates potential as a noninvasive therapy for reducing inflammation and altering immune cell function in skeletal muscle in insulin-resistant and diabetic populations. This study introduces low-frequency ultrasound (LFU) as a novel, noninvasive therapy that attenuates insulin resistance- and diabetes-induced transcriptional changes in aged skeletal muscle. LFU primarily reduced inflammatory and immune-related gene expression, potentially by promoting a shift toward an anti-inflammatory (M2) macrophage profile. These findings suggest that LFU may target underlying inflammatory mechanisms of insulin resistance and diabetes in aging muscle.
患胰岛素抵抗和II型糖尿病的风险会随着年龄增长而增加。尽管生活方式因素会导致与年龄相关的胰岛素抵抗,但衰老本身会独立降低胰岛素敏感性,部分原因是炎症和细胞衰老增加。低频超声(LFU)已被证明可使衰老细胞恢复活力,并减少促炎的衰老相关分泌表型。由于糖尿病在老年人中更为常见,因此越来越需要为患有这种疾病的老年人开发有效的治疗方法。本研究调查了LFU治疗对老年、胰岛素抵抗和糖尿病小鼠的肌肉功能、血糖控制和骨骼肌基因表达的影响。通过高脂高糖(HFHS)饮食诱导胰岛素抵抗,通过HFHS饮食加低剂量链脲佐菌素诱导糖尿病。胰岛素抵抗和糖尿病小鼠表现出葡萄糖代谢和身体功能受损,以及骨骼肌转录组谱改变,表明炎症和免疫反应增加。LFU治疗逆转了胰岛素抵抗和糖尿病时发生的许多转录组变化,但对血糖控制或身体功能没有影响。LFU显示出作为一种非侵入性疗法的潜力,可减少胰岛素抵抗和糖尿病人群骨骼肌中的炎症并改变免疫细胞功能。本研究引入低频超声(LFU)作为一种新型非侵入性疗法,可减轻胰岛素抵抗和糖尿病诱导的老年骨骼肌转录变化。LFU主要降低炎症和免疫相关基因的表达,可能是通过促进向抗炎(M2)巨噬细胞谱的转变。这些发现表明,LFU可能针对衰老肌肉中胰岛素抵抗和糖尿病的潜在炎症机制。